Health Catalyst Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Health Catalyst has been growing earnings at an average annual rate of 14.9%, while the Healthcare Services industry saw earnings growing at 14% annually. Revenues have been growing at an average rate of 15.3% per year.
Belangrijke informatie
14.9%
Groei van de winst
67.0%
Groei van de winst per aandeel
Healthcare Services Groei van de industrie | 1.7% |
Inkomstengroei | 15.3% |
Rendement op eigen vermogen | -24.2% |
Nettomarge | -28.9% |
Volgende winstupdate | 06 Nov 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Health Catalyst: Still Optimistic On Achieving Adjusted EBITDA Targets
Sep 24Health Catalyst, Inc.'s (NASDAQ:HCAT) Shares Lagging The Industry But So Is The Business
Jul 17Health Catalyst: Stellar Earnings Growth Projected
Jun 26Health Catalyst, Inc. (NASDAQ:HCAT) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 12Benign Growth For Health Catalyst, Inc. (NASDAQ:HCAT) Underpins Its Share Price
Apr 04Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible
Mar 09Health Catalyst Looks To Slim Down As It Faces Industry Headwinds (Downgrade)
Feb 16Is Health Catalyst (NASDAQ:HCAT) A Risky Investment?
Jan 27What Health Catalyst, Inc.'s (NASDAQ:HCAT) 25% Share Price Gain Is Not Telling You
Dec 24Is Health Catalyst, Inc. (NASDAQ:HCAT) Trading At A 47% Discount?
Dec 15Is Health Catalyst (NASDAQ:HCAT) Weighed On By Its Debt Load?
Oct 24Subdued Growth No Barrier To Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
Jul 31Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Jun 27Is Health Catalyst (NASDAQ:HCAT) Using Too Much Debt?
Feb 22Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 22% Above Their Intrinsic Value Estimate
Dec 06Is Health Catalyst (NASDAQ:HCAT) Using Debt In A Risky Way?
Nov 03Health Catalyst: Looking For A Turnaround For This 'Bio Boom' Candidate
Oct 14Health Catalyst names Kevin Freeman as Chief Growth Officer, Tarah Bryan as Chief Marketing Officer, Dave Ross as Chief Technology Officer
Sep 07Opbrengsten en kosten
Hoe Health Catalyst geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | 299 | -86 | 108 | 62 |
31 Mar 24 | 297 | -106 | 112 | 66 |
31 Dec 23 | 296 | -118 | 111 | 69 |
30 Sep 23 | 290 | -124 | 118 | 69 |
30 Jun 23 | 285 | -147 | 131 | 70 |
31 Mar 23 | 282 | -148 | 130 | 69 |
31 Dec 22 | 276 | -137 | 144 | 69 |
30 Sep 22 | 272 | -151 | 144 | 68 |
30 Jun 22 | 265 | -145 | 143 | 67 |
31 Mar 22 | 254 | -147 | 148 | 64 |
31 Dec 21 | 242 | -153 | 132 | 62 |
30 Sep 21 | 230 | -147 | 123 | 60 |
30 Jun 21 | 216 | -135 | 112 | 57 |
31 Mar 21 | 200 | -126 | 102 | 55 |
31 Dec 20 | 189 | -115 | 96 | 54 |
30 Sep 20 | 179 | -86 | 89 | 52 |
30 Jun 20 | 171 | -99 | 90 | 52 |
31 Mar 20 | 165 | -181 | 85 | 49 |
31 Dec 19 | 155 | -241 | 79 | 46 |
30 Sep 19 | 148 | -304 | 76 | 44 |
30 Jun 19 | 141 | -282 | 69 | 41 |
31 Mar 19 | 127 | -190 | 71 | 39 |
31 Dec 18 | 113 | -114 | 66 | 38 |
31 Dec 17 | 73 | -59 | 41 | 28 |
Kwaliteitswinsten: HCAT is currently unprofitable.
Groeiende winstmarge: HCAT is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: HCAT is unprofitable, but has reduced losses over the past 5 years at a rate of 14.9% per year.
Versnelling van de groei: Unable to compare HCAT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: HCAT is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (35.1%).
Rendement op eigen vermogen
Hoge ROE: HCAT has a negative Return on Equity (-24.21%), as it is currently unprofitable.